Suscribirse

Prevalence, Echocardiographic Correlations, and Clinical Outcome of Tricuspid Regurgitation in Patients with Significant Left Ventricular Dysfunction - 19/12/18

Doi : 10.1016/j.amjmed.2018.10.004 
Shirit Sara Kazum, MD a, Alexander Sagie, MD a, Tzippy Shochat, MSc b, Tuvia Ben-Gal, MD a, Tamir Bental, MD a, Ran Kornowski, MD a, Yaron Shapira, MD a, Mordehay Vaturi, MD a, Tal Hasin, MD a, c,
a Department of Cardiology 
b Statistical Consultant, Rabin Medical Center, Petah Tikva, Israel 
c Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel 

Requests for reprints should be addressed to Tal Hasin, MD, Department of Cardiology, Shaare Zedek Medical Center, 12 Byeth Street, Jerusalem 9103102 POB 3235, Israel.Department of CardiologyShaare Zedek Medical Center12 Byeth StreetJerusalem9103102 POB 3235,Israel

Abstract

Purpose

We initiated this study to evaluate the prevalence and clinical significance of tricuspid regurgitation in patients with left ventricular dysfunction.

Methods

A single-center analysis of all echocardiographic studies between 2000 and 2013 was performed. Patients with ejection fraction <35% were included, and those with mechanical valves, mitral stenosis, or significant aortic valve pathology were excluded. Patients were grouped based on tricuspid regurgitation severity (nonsignificant, moderate, and severe). Demographic and echocardiographic findings and survival were compared.

Results

The study included 3943 patients (74% male, age 69 ± 14 years); 70% had nonsignificant, 24% had moderate, and 6% had severe tricuspid regurgitation. In a multivariate model, tricuspid regurgitation was independently associated with older age (odds ratio [OR] 1.009; 95% confidence interval [CI], 1.001-1.017; P = .022), female sex (OR 1.644; 95% CI, 1.329-2.035; P < .001), atrial fibrillation (OR 1.764; 95% CI, 1.429-2.134; P < .001), tricuspid regurgitation gradient (OR 1.051; 95% CI, 1.045-1.058; P < .001 per mm Hg), right ventricular dysfunction (OR 3.492; 95% CI, 2.870-4.248; P < .001), left atrial area (cm2, OR 1.031; 95% CI, 1.013-1.049; P < .001), mitral regurgitation severity (P < .001), and lack of hypertension (OR 0.760; 95% CI, 0.616-0.936; P = .010) or obesity (OR 0.583; 95% CI, 0.427-0.796; P < .001). Patients were followed for a median of 8.15 years (interquartile range 4.75-11.42). Median survival was 4.88 years for nonsignificant, 2.3 years for moderate, and 1.6 years for patients with severe tricuspid regurgitation, significantly associated with tricuspid regurgitation severity (hazard ratio 1.513; 95% CI, 1.383-1.656 for moderate, hazard ratio 1.857; 95% CI, 1.606-2.148 for severe tricuspid regurgitation; P < .001), the association persisted after multiple adjustments.

Conclusions

Significant tricuspid regurgitation is common in patients with left ventricular dysfunction. It is linked to various cardiac pathologies and independently associated with increased mortality.

El texto completo de este artículo está disponible en PDF.

Keywords : Left ventricular dysfunction, Mortality, Prevalence, Tricuspid regurgitation


Esquema


 Funding: No external funding was used for this research.
 Conflict of Interest: None.
 Authorship: All authors had access to the data and role in writing this manuscript.


© 2019  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 132 - N° 1

P. 81-87 - janvier 2019 Regresar al número
Artículo precedente Artículo precedente
  • Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction
  • Essraa Bayoumi, Phillip H. Lam, Daniel J. Dooley, Steven Singh, Charles Faselis, Charity J. Morgan, Samir Patel, Helen M. Sheriff, Selma F. Mohammed, Carlos E. Palant, Bertram Pitt, Gregg C. Fonarow, Ali Ahmed
| Artículo siguiente Artículo siguiente
  • Inferior Vena Cava Filters in Patients with Recurrent Pulmonary Embolism
  • Paul D. Stein, Fadi Matta, Frank R. Lawrence, Mary J Hughes

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.